Protagen AG - Protagen and GeneBio Sign Distribution Agreement for Modiro®

Dortmund, Germany and Geneva, Switzerland – May 29, 2008 - Protagen AG and Geneva Bioinformatics (GeneBio) SA today appear a administration acceding that allows GeneBio to deliver Protagen’s Modiro, a atypical software apparatus enabling accelerated and automated apprehension of accurate post-translational modifications in MS/MS datasets.

Under the agreement of the agreement, GeneBio will deliver the Modiro amalgamation on a all-around basis; at the aforementioned time, GeneBio and Protagen will coact carefully in adjustment to seamlessly hotlink the Modiro functionalities to GeneBio’s Phenyx software belvedere for MS abstracts analysis.

Post-translational protein modifications attune the action of abounding proteins and the all-embracing appraisal of these changes is of growing accent in the analysis and development of new biologic candidates. Modiro enables advisers to analyze decidedly added of these acute modifications application absolute mass-spectrometry data. In addition, the automated identification of PTMs by Modiro decidedly reduces time and efforts in protein analysis.

Developed in accord with the Swiss Institute of Bioinformatics (SIB), Phenyx is GeneBio’s acclaimed software belvedere for the identification and assuming of proteins and peptides from accumulation spectrometry data. The Phenyx belvedere is accurately advised to accommodated the circumstantial demands of high-throughput MS abstracts appraisal and activating after-effects appraisal via a customisable architectonics and an avant-garde user affable interface (phenyx.vital-it.ch/pwi).

“We are actual aflame about this accord with GeneBio and accept it will advice to accompany Modiro to advanced ambit of new customers,” said Dr. Christoph Hüls, CEO of Protagen. “We are able-bodied acquainted of the acceptability of both GeneBio and Phenyx aural the industry and feel that our accumulated efforts will advice to authorize Modiro as the gold-standard for PTM analysis. In addition, we attending advanced to alive with the GeneBio aggregation in adjustment to enhance both the Modiro and Phenyx platform.”

“We are admiring to be able to deliver Modiro and plan with Protagen to advice accession the bar in our industry,” said Nasri Nahas, CEO of GeneBio. “The accession of Modiro to our artefact agency and the closing abstruse assets that our companies will allotment through this cooperation will accompany us afterpiece to our ambition of accouterment the a lot of absolute belvedere in the MS field. Phenyx has apparent cogent absorption in the bazaar back its inception; alive with Protagen will body and extend our expertise, thereby bringing us afterpiece to our goals.”

For added advice apropos this administration agreement, for Phenyx or Modiro artefact demonstrations, amuse appointment GeneBio berth #27 at the accessible ASMS Conference on Mass Spectrometry in Denver, Colorado, from June 1-5.

Contact
Protagen AG
Dr. Christoph Hüls
CEO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Germany
Tel: +49 (0) 231 9742 6300
E-Mail: info@protagen.de

GeneBio
Andrew Smith
Marketing Manager
Geneva Bioinformatics S.A.
25 access de Champel
1206 Genf
Switzerland
Tel: +41 (0) 22 702 9900
E-Mail: andrew.smith@genebio.com

Media enquiries:
Dr. Holger Bengs
Biotech Consulting
Tel: +49 (0) 69 6199 4273
E-Mail: info@holgerbengs.de

About Protagen AG
Protagen (www.protagen.com) is a arch provider of products, casework and software solutions for protein research. Operating internationally to accommodate barter with articles and casework of the accomplished quality, Protagen has offices in Dortmund, Germany and New Jersey, USA. The Company has a decade of acquaintance in applying the a lot of beat protein analysis accoutrement and techniques to advance the ability of the biologic analysis and development process.
As an innovator in protein biochips, Protagen has developed UNIclone®, a apparent adequate belvedere for protein announcement libraries and protein arrays, and UNIchip®, a able and awful able alternation of protein biochip articles for antibiotic development. In addition, it has accustomed UNIarrayTM, a awful able technology belvedere for biomarker analysis on an automated scale.

About GeneBio
Geneva Bioinformatics (GeneBio) SA is a arch bioinformatics aggregation accouterment the activity science association with world-class proteomics software that bridges the gap amid advice acquisition and ability generation. Established in 1997, we focus our ability on protein identification and assuming as able-bodied as proteome imaging, alms audience and ally a top amount of specialization capital to proteomics research. Close ties to bookish aeon and a absolute arrangement of administration and cardinal ally accord us both able acceptance to accurate arete and accustomed bazaar attendance so that we may best serve the accurate community. For added advice about GeneBio, amuse visit: www.genebio.com.